Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
82.45
-0.08 (-0.10%)
Nov 21, 2024, 4:00 PM EST - Market closed
Belite Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,524 | 1,263 | 750 | - | - |
| Market Cap Growth | 65.48% | 68.44% | - | - | - |
| Enterprise Value | 2,439 | 1,221 | 701 | - | - |
| Last Close Price | 82.53 | 45.75 | 30.14 | - | - |
| PB Ratio | 22.71 | 13.96 | 18.06 | - | - |
| P/TBV Ratio | 12.79 | 13.96 | 18.06 | - | - |
| Debt / Equity Ratio | - | 0.01 | 0.02 | - | - |
| Quick Ratio | - | 24.50 | 20.01 | 10.61 | 26.36 |
| Current Ratio | 30.73 | 24.76 | 20.35 | 10.66 | 26.41 |
| Return on Equity (ROE) | -40.04% | -47.95% | -43.45% | -46.60% | - |
| Return on Assets (ROA) | -25.58% | -28.50% | -25.59% | -27.78% | - |
| Return on Capital (ROIC) | -26.89% | -29.61% | -27.13% | -29.52% | - |
| Earnings Yield | -1.31% | -2.51% | -1.69% | - | - |
| FCF Yield | -2.37% | -1.58% | - | - |
| Buyback Yield / Dilution | -15.58% | -33.12% | -108.74% | -8.87% | - |
| Total Shareholder Return | -15.58% | -33.12% | -108.74% | -8.87% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.